Edition:
United Kingdom

Acer Therapeutics Inc (ACER.OQ)

ACER.OQ on NASDAQ Stock Exchange Capital Market

19.83USD
23 Apr 2019
Change (% chg)

-- (--)
Prev Close
$19.83
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,759
52-wk High
$34.10
52-wk Low
$16.32

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -0.844
Sep '18 0.00 -0.434
Jun '18 0.00 -0.645
Mar '18 0.00 -0.531
FY 2017 Dec '17 0.00 -0.396
Sep '17 0.00 -0.539
Jun '17 0.00 -0.917
Mar '17 0.00 -0.451
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 5 0.04 0.20 0.00 --
Quarter Ending Sep-19 5 2.18 5.34 0.55 --
Year Ending Dec-19 6 7.11 14.90 2.00 18.57
Year Ending Dec-20 6 50.76 79.59 30.40 56.50
Earnings (per share)
Quarter Ending Jun-19 5 -0.86 -0.61 -1.05 --
Quarter Ending Sep-19 5 -0.69 -0.50 -0.98 --
Year Ending Dec-19 5 -2.81 -2.30 -3.50 -2.19
Year Ending Dec-20 6 0.22 4.37 -1.22 0.08
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 110.59 62.94
P/E High - Last 5 Yrs. -- 162.88 56.44
P/E Low - Last 5 Yrs. -- 52.22 28.76
Beta 2.52 1.17 0.93
Price to Sales (TTM) -- 45.83 9.69
Price to Book (MRQ) 4.60 13.27 4.53
Price to Tangible Book (MRQ) 5.56 18.94 8.07
Price to Cash Flow (TTM) -- 73.77 43.55
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.09 1.54
Dividend Yield - 5 Year Avg -- 0.05 0.70
Dividend 5 Year Growth Rate -- 0.71 2.98
Payout Ratio(TTM) -- 8.47 21.89

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 22.25 9.11
Sales (TTM) vs TTM 1 Yr. Ago -- 66.82 8.34
Sales - 5 Yr. Growth Rate -- 33.24 11.19
EPS (MRQ) vs Qtr. 1 Yr. Ago -112.96 -90.31 112.52
EPS (TTM) vs TTM 1 Yr. Ago -26.28 -- --
EPS - 5 Yr. Growth Rate -- 21.66 6.94
Capital Spending - 5 Yr. Growth Rate -18.08 25.54 7.63

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.81 2.67
Current Ratio (MRQ) 7.66 3.64 3.63
LT Debt to Equity (MRQ) 0.00 7.02 13.38
Total Debt to Equity (MRQ) 0.00 20.04 17.12
Interest Coverage (TTM) -56.85 11.13 27.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 25.49 50.33
Gross Margin - 5 Yr. Avg. -- 60.05 50.77
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -1,021.26 -10.78 15.75
Operating Margin (TTM) -- -108.32 -2.12
Operating Margin - 5 Yr. Avg. -1,051.69 -26.36 11.07
Pre-Tax Margin (TTM) -- -109.04 -2.97
Pre-Tax Margin - 5 Yr. Avg. -1,047.42 -29.08 16.81
Net Profit Margin (TTM) -- -115.42 -6.92
Net Profit Margin - 5 Yr. Avg. -1,047.42 -34.27 11.75
Effective Tax Rate (TTM) -- 19.94 22.89
Effective Tax Rate - 5 Yr. Avg. -- 19.62 23.86

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 8,473,856 767,389,378
Net Income/Employee (TTM) -925,256 1,875,927 88,365,779
Receivable Turnover (TTM) -- 2.36 5.22
Inventory Turnover (TTM) -- 2.32 3.64
Asset Turnover (TTM) 0.00 0.32 0.80

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.72 6.37 9.51
Return on Assets - 5 Yr. Avg. -76.82 6.26 10.45
Return on Investment (TTM) -63.13 8.01 11.75
Return on Investment - 5 Yr. Avg. -92.11 8.20 13.34
Return on Equity (TTM) -63.13 8.19 12.58
Return on Equity - 5 Yr. Avg. -113.69 9.32 14.82
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -31.39 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Acer Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -12.40 -15.70 20 91
13 Week -17.73 -24.44 21 82
26 Week -13.47 -17.99 44 9
52 Week 9.65 0.69 71 27
YTD 2.19 -11.91 37 28
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 59.78%
# of Holders: 43
Total Shares Held: 6,029,728
3 Mo. Net Change: 7,381
# New Positions: 2
# Closed Positions: 1
# Increased Positions: 4
# Reduced Positions: 1
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.